Skip to content

Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya

Evaluation of Applicability of Urine Based Schistosomiasis Test Strip in the Epidemiologic Mapping and Sampling of Schistosoma Mansoni Infection in Low Endemic Areas of Kenya

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00463307
Enrollment
1100
Registered
2007-04-20
Start date
2006-04-30
Completion date
2006-11-30
Last updated
2007-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulating Cathodic Antigen Urine Based Dipstick, Schistosomiasis Mansoni

Keywords

schistosomiasis, Schistosoma mansoni, Circulating cathodic antigen urine dipstick

Brief summary

The purpose of this study is to evaluate the use of a urine test strip in diagnose schistosoma mansoni in areas of Kenya where the rate of infections are low. The hypothesis is that the urine strip test is a superior tool to the conventional parasitological tools used to diagnose schistosomiasis mansoni infections in area where there is low transmission

Detailed description

The study will compare the use of the urine test strip with the conventional method used and with a golden standard methode, in an area of Kenya where the infection transmission is low. Furthermore will the urine test strip be evaluatied in its ability to monitor the intensity of infections in school children before and after they are been treated for the infections. A total of 1100 school children in the age between 10 and 18 years will be included in the study. Children have to submitt a stool and a urine sample on three consecutive days. Children who are found to be infected with the schistosomiasis parasite will be offered treatment.

Interventions

None listed

Sponsors

DBL -Institute for Health Research and Development
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children in the age between 10 and 18 years

Exclusion criteria

* Children younger then 10 years of age and children whos parent/guardians did not give informed consents for their participation in the study

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026